Last reviewed · How we verify
NCT05218863: AMESI
Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischemia
trial testing No intervention in Acute Mesenteric Ischemia in 709 participants. Completed in 5 April 2023.
5 April 2023
Quick facts
| Lead sponsor | University of Tartu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 709 |
| Start date | 6 June 2022 |
| Primary completion | 5 April 2023 |
| Estimated completion | 5 April 2023 |
| Sites | 3 locations across Estonia, Switzerland |
Drugs / interventions tested
- No intervention
Conditions studied
- Acute Mesenteric Ischemia — all drugs for Acute Mesenteric Ischemia →
Sponsor
University of Tartu
Who can join
18 and older, any sex, with Acute Mesenteric Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, multicentre observational study screening all adult patients admitted to a participating hospital over a 6-month study period (may be adjusted to 4-8 months according to recruitment) and including all patients with suspicion of or confirmed acute mesenteric ischaemia (AMI). Only admission data and hospital mortality outcome will be collected for patients in whom suspicion of AMI is not confirmed. For patients with confirmed AMI full data collection regarding diagnostics, management and long-term outcome is required. Investigators aim to recruit 40-50 sites with expected median of 10-20 patients with confirmed AMI per site during the study period (naturally depending on the size of the hospital). The start of the study is planned for Spring 2022. The aim of the study is to identify the incidence of AMI and its different forms in adult hospitalized patients, and to describe patient characteristics (demographic, clinical and laboratory) at baseline, applied diagnostics and management, as well as outcomes in patients with AMI. An additional aim is to compare the baseline characteristics and outcomes of patients with confirmed AMI to those of patients with suspected AMI in whom the diagnosis was not confirmed.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis.
Tamme K, Reintam Blaser A, Laisaar KT, Mändul M, et al · · 2022 · cited 52× · PMID 36283747 · DOI 10.1136/bmjopen-2022-062846 -
Incidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicentre observational study (AMESI Study).
Reintam Blaser A, Mändul M, Björck M, Acosta S, et al · · 2024 · cited 42× · PMID 38263058 · DOI 10.1186/s13054-024-04807-4 -
D-Dimer in Acute Mesenteric Venous Thrombosis: A Prospective Case-Control International Multicenter Study.
Acosta S, Blaser AR, Nuzzo A, Soltanzadeh-Naderi Y, et al · · 2024 · cited 3× · PMID 39600492 · DOI 10.1177/11772719241296631
Verify or expand the search:
- PubMed search for NCT05218863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Acute Mesenteric Ischemia
Currently open trials in the same condition.
- NCT06869564 — Evaluation of the Discriminative Abilities of Biomarkers for the Diagnosis of Acute Mesenteric Ischemia Compared With An · NA · recruiting
- NCT06387147 — ORal Antibiotics in Acute Mesenteric Ischemia · Phase 3 · recruiting
- NCT06445660 — The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia · recruiting
- NCT03518099 — Searching Biomarkers of Acute Intestinal Ischemic Injuries · NA · recruiting
Other University of Tartu trials
Trials by the same sponsor.
- NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
- NCT07276490 — Central Haemodynamics and Pacing for AV Block · NA · recruiting
- NCT06829004 — Calf Circumference Adjusted for Body Composition to Assess Muscle Mass · not yet recruiting
- NCT06873880 — Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients · recruiting
- NCT06768788 — Long-term Impact of PE Teacher Interventions on Adolescent Leisure Time Activity and Motivation · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05218863 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tartu
- Last refreshed: 31 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05218863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing